Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Lyn M. Duncan, M.D.


This page shows the publications co-authored by Lyn Duncan and Elena Hawryluk.
Connection Strength

  1. The evolving nomenclature of spitzoid proliferations-Pediatric outcomes are favorable, regardless of name. Pediatr Dermatol. 2020 Nov; 37(6):1083-1084.
    View in: PubMed
    Score: 0.936
  2. Histologically challenging melanocytic tumors referred to a tertiary care pigmented lesion clinic. J Am Acad Dermatol. 2012 Oct; 67(4):727-35.
    View in: PubMed
    Score: 0.518
  3. A 20-year histopathologic study of pediatric nevi at an academic institution. J Am Acad Dermatol. 2021 01; 84(1):39-40.
    View in: PubMed
    Score: 0.230
  4. Contrasting features of childhood and adolescent melanomas. Pediatr Dermatol. 2018 May; 35(3):354-360.
    View in: PubMed
    Score: 0.195
  5. Broad range of adverse cutaneous eruptions in patients on TNF-alpha antagonists. J Cutan Pathol. 2012 May; 39(5):481-92.
    View in: PubMed
    Score: 0.130
  6. Clinical spectrum of cutaneous melanoma morphology. J Am Acad Dermatol. 2019 Jan; 80(1):178-188.e3.
    View in: PubMed
    Score: 0.050
  7. BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition. Proc Natl Acad Sci U S A. 2013 Mar 12; 110(11):4321-6.
    View in: PubMed
    Score: 0.034
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.